Asia Pacific Benign Prostatic Hyperplasic Devices Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Resectoscopes, Urology Laser, Radiofrequency Ablation Devices, Prostatic Stents, and Implants), Procedure Type (Transurethral Microwave Therapy, Transurethral Resection of the Prostate, Transurethral Needle Ablation of the Prostate, Laser Surgery, Urolift Surgery, and Others), and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

No. of Pages: 157    |    Report Code: BMIRE00027116    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Benign Prostatic Hyperplasic Devices Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Benign Prostatic Hyperplasic Devices Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Benign Prostatic Hyperplasic Devices Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Growing geriatric population globally.
  • 5.1.3 Increasing awareness about BPH treatments.
  • 5.1.4 Advancements in minimally invasive devices.
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Expansion in telehealth and remote care.
  • 5.2.3 Development of laser-based treatment devices.
  • 5.2.4 Demand for cost-effective solutions.
5.3 Future Trends
  • 5.3.1
  • 5.3.2 AI integration in diagnostic tools.
  • 5.3.3 Personalized BPH treatment approaches.
  • 5.3.4 Growing adoption of robotic-assisted devices.
5.4 Impact of Drivers and Restraints

6. Asia Pacific Benign Prostatic Hyperplasic Devices Market Regional Analysis

6.1 Asia Pacific Benign Prostatic Hyperplasic Devices Market Overview
6.2 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue 2020-2028 (US$ Million)
6.3 Asia Pacific Benign Prostatic Hyperplasic Devices Market Forecast Analysis

7. Asia Pacific Benign Prostatic Hyperplasic Devices Market Analysis – by Product

7.1 Resectoscopes
  • 7.1.1 Overview
  • 7.1.2 Resectoscopes: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Urology Laser
  • 7.2.1 Overview
  • 7.2.2 Urology Laser: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Radiofrequency Ablation Devices
  • 7.3.1 Overview
  • 7.3.2 Radiofrequency Ablation Devices: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Prostatic Stents
  • 7.4.1 Overview
  • 7.4.2 Prostatic Stents: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Implants
  • 7.5.1 Overview
  • 7.5.2 Implants: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Benign Prostatic Hyperplasic Devices Market Analysis – by Procedure Type

8.1 Transurethral Microwave Therapy
  • 8.1.1 Overview
  • 8.1.2 Transurethral Microwave Therapy: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Transurethral Resection of the Prostate
  • 8.2.1 Overview
  • 8.2.2 Transurethral Resection of the Prostate: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Transurethral Needle Ablation of the Prostate
  • 8.3.1 Overview
  • 8.3.2 Transurethral Needle Ablation of the Prostate: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Laser Surgery
  • 8.4.1 Overview
  • 8.4.2 Laser Surgery: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Urolift Surgery
  • 8.5.1 Overview
  • 8.5.2 Urolift Surgery: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Benign Prostatic Hyperplasic Devices Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Urolift Surgery: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Urolift Surgery: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Ambulatory Surgical Centers
  • 9.3.1 Overview
  • 9.3.2 Urolift Surgery: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Benign Prostatic Hyperplasic Devices Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.1.2 China: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.1.3 China: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by End User
  • 10.1.1.2 India: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.2.2 India: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.2.3 India: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by End User
  • 10.1.1.3 Japan: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.3.2 Japan: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.3.3 Japan: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by End User
  • 10.1.1.4 Australia: Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.4.2 Australia: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.4.3 Australia: Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by End User
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Benign Prostatic Hyperplasic Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Benign Prostatic Hyperplasic Devices Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 KARL STORZ SE & Co. KG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Olympus Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Boston Scientific Corporation
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Teleflex Incorporated
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Richard Wolf GmbH
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 GmbH
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Asia Pacific Benign Prostatic Hyperplasic Devices Market

  1. KARL STORZ SE & Co. KG
  2. Olympus Corporation
  3. Boston Scientific Corporation
  4. Teleflex Incorporated
  5. Richard Wolf GmbH
  6. GmbH